Jagotec

Pharma

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 1 drug with upcoming expirations

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

1 patent group across drugs · Source: FDA Orange Book

DrugExpires

TricorMay 31, 2033

Regulatory

Regulatory Timeline

19931 event

FDADec 31

Tricor — LIPIDIL

Application NDA019304 (NDA)

20011 event

FDASep 4

Tricor — TRICOR

Application NDA021203 (NDA)

20041 event

FDANov 5

Tricor — TRICOR

Application NDA021656 (NDA)

20051 event

FDAMay 7

Tricor — TRIGLIDE

Application NDA021350 (NDA)

20061 event

FDAJan 11

Tricor — LIPOFEN

Application NDA021612 (NDA)

20071 event

FDAAug 10

Tricor — FENOGLIDE

Application NDA022118 (NDA)

20131 event

FDAOct 18

Tricor — ANTARA (MICRONIZED)

Application NDA021695 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)